Compare DXR & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DXR | PNI |
|---|---|---|
| Founded | 1970 | 2002 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.4M | 79.1M |
| IPO Year | N/A | N/A |
| Metric | DXR | PNI |
|---|---|---|
| Price | $12.40 | $7.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | 7.4K | ★ 26.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.76% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $34.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.00 | $6.03 |
| 52 Week High | $14.76 | $7.89 |
| Indicator | DXR | PNI |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 62.15 |
| Support Level | $12.15 | $7.05 |
| Resistance Level | $12.90 | $7.16 |
| Average True Range (ATR) | 0.44 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 16.67 | 74.04 |
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.